Vyome Holdings, Inc. (HIND)
2.19
-0.05
(-2.32%)
USD |
NASDAQ |
Aug 25, 09:59
Vyome Holdings Price to Book Value : 2.541 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.602 |
| August 21, 2026 | 2.611 |
| August 20, 2026 | 2.646 |
| August 19, 2026 | 2.692 |
| August 18, 2026 | 2.634 |
| August 17, 2026 | 2.634 |
| August 14, 2026 | 2.530 |
| August 13, 2026 | 2.506 |
| August 12, 2026 | 2.576 |
| August 11, 2026 | 2.611 |
| August 10, 2026 | 2.564 |
| August 07, 2026 | 2.506 |
| August 06, 2026 | 2.483 |
| August 05, 2026 | 2.483 |
| August 04, 2026 | 2.518 |
| August 03, 2026 | 2.512 |
| July 31, 2026 | 2.454 |
| July 30, 2026 | 2.332 |
| July 29, 2026 | 2.309 |
| July 28, 2026 | 2.309 |
| July 27, 2026 | 2.321 |
| July 24, 2026 | 2.390 |
| July 23, 2026 | 2.483 |
| July 22, 2026 | 2.461 |
| July 21, 2026 | 2.530 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.541 |
| July 17, 2026 | 2.495 |
| July 16, 2026 | 2.541 |
| July 15, 2026 | 2.634 |
| July 14, 2026 | 2.530 |
| July 13, 2026 | 2.599 |
| July 10, 2026 | 2.611 |
| July 09, 2026 | 2.588 |
| July 08, 2026 | 2.472 |
| July 07, 2026 | 2.553 |
| July 06, 2026 | 2.588 |
| July 02, 2026 | 2.669 |
| July 01, 2026 | 2.611 |
| June 30, 2026 | 2.495 |
| June 29, 2026 | 2.217 |
| June 26, 2026 | 2.248 |
| June 25, 2026 | 2.196 |
| June 24, 2026 | 2.186 |
| June 23, 2026 | 2.206 |
| June 22, 2026 | 2.258 |
| June 18, 2026 | 2.258 |
| June 17, 2026 | 2.269 |
| June 16, 2026 | 2.290 |
| June 15, 2026 | 2.258 |
| June 12, 2026 | 2.394 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cardiac Biotech Solutions, Inc. | -- |
| Anika Therapeutics, Inc. | 2.117 |
| Enovis Corp. | 0.9690 |
| Edwards Lifesciences Corp. | 4.900 |
| Perspective Therapeutics, Inc. | 1.161 |
Price to Book Value Related Metrics
| PS Ratio | 94.50 |
| Price to Free Cash Flow | 23.37 |
| Price | 2.19 |
| Earnings Yield | -160.1% |
| Market Cap | 15.37M |